Multiple lines of evidence indicate an interaction between amyloid-beta (Aβ) and tau protein in Alzheimer's disease, and tau protein is required for the effect of Aβ in many experimental paradigms. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.